Trial Profile
Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Modimelanotide (Primary)
- Indications Acute kidney injury
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Action Pharma
- 17 Sep 2014 New trial record